Keith Flaherty's Insider Trades & SAST Disclosures

Keith Flaherty's most recent trade in Kinnate Biopharma Inc was a trade of 25,000 Stock Option (right to buy) done . Disclosure was reported to the exchange on June 12, 2023.

Stock Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Kinnate Biopharma Inc
Keith Flaherty Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Jun 2023 25,000 25,000 - - Stock Option (right to buy)
Kinnate Biopharma Inc
Keith Flaherty Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jun 2022 20,250 20,250 - - Stock Option (right to buy)
Kinnate Biopharma Inc
Keith Flaherty Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Jun 2021 20,250 20,250 - - Stock Option (right to buy)
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades